Janus Henderson Group
VIR icon

Janus Henderson Group’s Vir Biotechnology VIR Stock Holding History

Janus Henderson Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Buy
54,789
+17,732
+48% +$141K ﹤0.01% 2013
2025
Q4 		$223K Hold
37,057
– – ﹤0.01% 2316
2025
Q3 		$212K Hold
37,057
– – ﹤0.01% 2325
2025
Q2 		$187K Hold
37,057
– – ﹤0.01% 2334
2025
Q1 		$248K Hold
37,057
– – ﹤0.01% 2289
2024
Q4 		$271K Hold
37,057
– – ﹤0.01% 2296
2024
Q3 		$277K Hold
37,057
– – ﹤0.01% 2300
2024
Q2 		$330K Sell
37,057
-456
-1% -$4.37K ﹤0.01% 2164
2024
Q1 		$380K Buy
37,513
+5
+0% +$51 ﹤0.01% 2132
2023
Q4 		$377K Sell
37,508
-57
-0.2% -$521 ﹤0.01% 2118
2023
Q3 		$352K Buy
37,565
+14
+0% +$200 ﹤0.01% 2111
2023
Q2 		$921K Sell
37,551
-165
-0.4% -$4.14K ﹤0.01% 1650
2023
Q1 		$878K Buy
37,716
+24,522
+186% +$627K ﹤0.01% 1708
2022
Q4 		$334K Sell
13,194
-1
-0% -$25 ﹤0.01% 1927
2022
Q3 		$255K Sell
13,195
-168
-1% -$4.27K ﹤0.01% 1803
2022
Q2 		$340K Buy
13,363
+281
+2% +$6.56K ﹤0.01% 2000
2022
Q1 		$336K Buy
13,082
+22
+0.2% +$653 ﹤0.01% 2149
2021
Q4 		$547K Sell
13,060
-29,003
-69% -$1.14M ﹤0.01% 1841
2021
Q3 		$1.83M Buy
+42,063
New +$1.82M ﹤0.01% 1270
2020
Q3 		– Sell
-950,310
Closed -$38.9M – 1363
2020
Q2 		$38.9M Buy
+950,310
New +$31.9M 0.02% 557

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB Investment Advisers (UK)
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Janus Henderson Group's VIR Position: Q1 2026 in Review

Janus Henderson Group increased its Vir Biotechnology (VIR) stake by 48% in Q1 2026, buying an estimated $141K and bringing the position to 54,789 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

Janus Henderson Group first reported a position in VIR in Q2 2020 and has held it in 20 quarters since. The position peaked at $38.9M in Q2 2020. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Janus Henderson Group held 54,789 shares of Vir Biotechnology worth $491K as of Q1 2026.
  • Janus Henderson Group bought 17,732 Vir Biotechnology shares in Q1 2026, an estimated $141K.
  • Vir Biotechnology made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2013 holding.
  • Janus Henderson Group first reported a position in Vir Biotechnology in Q2 2020 and has held it in 20 quarters since.
  • Janus Henderson Group's Vir Biotechnology position peaked at $38.9M in Q2 2020.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.